Researchers reveal link between PCOS, type 2 diabetes

August 29, 2017, The Endocrine Society

Women who have polycystic ovary syndrome (PCOS) have a higher risk of developing type 2 diabetes (T2D) and are diagnosed at an earlier age with the condition, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism. The nationwide study is the first to show a connection between T2D development and PCOS.

"Many with PCOS are obese, but the risk for the development of in PCOS is unknown," said one of the study's authors, Dorte Glintborg, M.D., Ph.D., of the Odense University Hospital in Denmark. "In this study, we found that the risk of developing diabetes is four times greater and that diabetes is diagnosed four years earlier in women with PCOS compared to controls."

An estimated 5 million to 6 million women in the United States have PCOS, according to the Hormone Health Network. It is one of the most common endocrine conditions in women of childbearing age.

Women who have PCOS produce slightly higher amounts of testosterone and other androgen hormones than average. Although these reproductive hormones are typically associated with men, women also have small amounts. The elevated levels in women with PCOS can contribute to irregular or absent menstrual periods, infertility, weight gain, acne or excess hair on the face and body. Women who have PCOS also face a higher risk of developing other health problems, such as diabetes.

To determine the risk of T2D development in women with PCOS, researchers studied two populations with PCOS: All pre-menopausal Danish women with a diagnosis of PCOS in the National Patient Register (18,477 women) and a local sub-group of 1,162 women with PCOS who were examined at Odense University Hospital in Denmark. The local participants were tested for insulin and , cholesterol, triglycerides and testosterone levels. Women with PCOS were compared with age-matched females who did not have the disorder, nor a previous diagnosis of T2D. Three women without PCOS were randomly selected from the Nation Patient register for each woman with PCOS.

Researchers found that women with PCOS were four times more likely to develop T2D compared to their counterparts who did not have the disorder. The average age for women with PCOS who received a diagnosis of T2D was 31 years. The average age for women without PCOS and diagnosed with T2D was 35 years.

Researchers also examined various factors related to T2D development in PCOS such as age, (BMI), number of pregnancies and prescriptions for oral contraceptives. Researchers used diagnosis codes in the Danish National Patient Register and medical prescriptions from the National Prescriptions Registry to make their findings.

Body mass index, insulin and glucose levels, and triglycerides were positively associated with development of T2D, whereas a higher number of births were negatively associated with the development of T2D.

The study's authors note that BMI and fasting blood glucose levels are the best predictors of the development of T2D in patients with PCOS. Increasing age, however, should not be included in future guidelines as a risk factor because most cases of diabetes in this study were found before the age of 40. The authors add that further research is needed to evaluate the effect of and number of births for the risk of T2D development in PCOS.

"The increased risk of developing T2D in PCOS is an important finding," Glintborg said. "Diabetes may develop at a young age and screening for diabetes is important, especially in women who are obese and have PCOS."

Explore further: Hormone from fat tissue can give protection against polycystic ovary syndrome

More information: Journal of Clinical Endocrinology & Metabolism, jc.2017-01354, DOI: 10.1210/jc.2017-01354

Related Stories

Hormone from fat tissue can give protection against polycystic ovary syndrome

August 10, 2017
Obesity and reduced insulin sensitivity are common in polycystic ovary syndrome, PCOS. New research based on animal studies, and to be published in the journal PNAS, reveals that the hormone adiponectin can protect against ...

Risk of fractures reduced in polycystic ovary syndrome

November 16, 2015
(HealthDay)—The risk of fractures is reduced in women with polycystic ovary syndrome (PCOS), according to a study published online Nov. 6 in the Journal of Bone and Mineral Research.

Study uncovers link between male hormones and metabolic disease in polycystic ovary syndrome

June 22, 2017
Scientists from the University of Birmingham have discovered the link between increased male hormones and metabolic complications such as diabetes and fatty liver disease in patients with polycystic ovary syndrome (PCOS).

Resveratrol can help correct hormone imbalance in women with PCOS

October 18, 2016
Resveratrol—a natural compound found in red wine and grapes—can help address a hormone imbalance in women with polycystic ovary syndrome (PCOS), a leading cause of infertility in women, according to a new study published ...

PCOS diagnosis tied to inflammation during pregnancy

May 29, 2014
Women who have polycystic ovary syndrome – the most common hormone disorder in women of reproductive age – are more likely to experience chronic low-grade inflammation during pregnancy than counterparts who do not have ...

Measuring new hormone may reduce teenagers wrongly diagnosed with PCOS

September 12, 2016
Measuring blood levels of the recently discovered hormone irisin may improve diagnosis rates of teenagers with polycystic ovary syndrome, according to research presented today at the 55th Annual European Society for Paediatric ...

Recommended for you

Discovery promises improved diagnosis and understanding of endometriosis

March 19, 2018
Feinstein Institute for Medical Research scientists announced an experimental, rapid and non-invasive way to diagnose endometriosis, which may lead to earlier and more effective treatments for this disorder that affects approximately ...

Vaginal estrogen tablets, moisturizers and placebo gel all can improve vaginal discomfort

March 19, 2018
A clinical trial comparing two treatments for postmenopausal vaginal discomfort - low-dose vaginal estrogen and a vaginal moisturizer - to placebo treatments found that both produced symptom improvements similar to those ...

Frozen embryos more successful for conceiving during IVF

March 19, 2018
A new study carried out by a research team at The University of Western Australia and Fertility Specialists of Western Australia has found that women undergoing IVF who have had embryos fail to implant have more success using ...

Alomst 70 percent of 103 genes linked to prenatal death affect the placenta

March 14, 2018
The role of the placenta in healthy fetal development is being seriously under-appreciated according to a new paper published today (14th March). The study was part of the Wellcome Trust-funded "Deciphering the Mechanisms ...

New research shows why babies need to move in the womb

March 12, 2018
Scientists have just discovered why babies need to move in the womb to develop strong bones and joints. It turns out there are some key molecular interactions that are stimulated by movement and which guide the cells and ...

Labour–inducing drugs put to the test

February 27, 2018
Researchers comparing the use of two drugs for pregnant women who do not go into labour shortly after their waters break have found both are reasonable options.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.